As shown in Figure 1, AGAP2-AS1 was significantly overexpressed in a large number of carcinomas, including glioma, LC, CLC, OC, PTC, CHOL, BLCA, CRC, PC and ccRCC. This evidence concerns the gene AGAP2 and bladder transitional cell carcinoma.